Jerry S. Lanchbury
2017
In 2017, Jerry S. Lanchbury earned a total compensation of $1.8M as Chief Scientific Officer at Myriad Genetics, a 33% decrease compared to previous year.
Compensation breakdown
| Bonus | $307 |
|---|---|
| Non-Equity Incentive Plan | $214,795 |
| Salary | $493,782 |
| Stock Awards | $1,095,000 |
| Other | $10,960 |
| Total | $1,814,844 |
Lanchbury received $1.1M in stock awards, accounting for 60% of the total pay in 2017.
Lanchbury also received $307 in bonus, $214.8K in non-equity incentive plan, $493.8K in salary and $11K in other compensation.
Rankings
In 2017, Jerry S. Lanchbury's compensation ranked 5,977th out of 14,666 executives tracked by ExecPay. In other words, Lanchbury earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,977 out of 14,666 | 59th |
Division Manufacturing | 2,190 out of 5,772 | 62nd |
Major group Chemicals And Allied Products | 686 out of 2,075 | 67th |
Industry group Drugs | 531 out of 1,731 | 69th |
Industry In Vitro and In Vivo Diagnostic Substances | 17 out of 72 | 76th |
Source: SEC filing on October 12, 2017.
Lanchbury's colleagues
We found four more compensation records of executives who worked with Jerry S. Lanchbury at Myriad Genetics in 2017.